Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 5;103(1):65-72.
doi: 10.62438/tunismed.v103i1.5220.

The primary mechanisms underlying atopic dermatitis

Affiliations
Review

The primary mechanisms underlying atopic dermatitis

Sara Missaoui et al. Tunis Med. .

Abstract

Introduction: Atopic dermatitis (AD) is a complex skin disease frequently linked with other atopic symptoms such allergic rhinitis and asthma. The disease's history consists of persistent relapses with extreme pruritus, which lowers quality of life. AD has become a global health concern as its incidence has increased over the last few decades. It ranks as the third most common dermatologic disorder.

Aim: There are several open questions about the mechanisms underlying atopic dermatitis (AD), This review aims to emphasize the recent advances in scientific research regarding the pathophysiologic mechanism of AD and the clinical application of these factors.

Methods: A PubMed search was performed using the keywords "Atopic Dermatitis (AD)", "epidemiology", "clinical presentation", "diagnosis", "pathophysiology", "genetic defect", "impaired skin barrier", "immune dysregulation". The search strategy included meta-analyses, clinical trial, observational studies, and reviews.

Results: Atopic dermatitis affects over 2 million children worldwide, with a lifetime incidence of up to 20%. New data suggest that its incidence is still growing, particularly in low-income nations. AD is diagnosed clinically using the patient's medical history, particular clinical symptoms, and the elimination of other non-inflammatory skin conditions. The pathogenesis of AD is extremely complicated and involves several etiologies, including genetics, the microbiome, abnormalities in the skin barrier, along with dysfunctional innate and adaptive immune systems.

Conclusion: Recent research has improved our understanding of disease pathophysiology in atopic dermatitis. Current and future clinical trials are expected to continue clarifying this complex and heterogeneous skin disease, and to develop medications that promise more effective therapy, particularly for individuals with limited response to conventional treatments.

Keywords: Atopic Dermatitis (AD); clinical presentation; diagnosis; genetic; pathophysiology; treatment.

PubMed Disclaimer

Figures

None
Figure 1. Approximate Distribution of Age at Onset for Symptoms of Atopic Dermatitis
None
Table 1. Clinical manifestations of AD(20–22).
None
Table 2. Diagnostic criteria for AD(21,22).
None
Figure 2. Pathogenesis of atopic dermatitis. FLG; filaggrin, Th2 cell; T helper type 2 cell, Th22 cell; T helper type 22 cell, IL; interleukin, TSLP; thymic stromal lymphopoietin, IgE; immunoglobulin-E, H4R; histamine-4 receptor, ILC2; group 2 innate lymphoid cells.
None
Table 3. Main groups of genes linked to the development of atopic dermatitis AD(40–45,45–55).
None
Table 4. Example of some current therapeutic pipeline for atopic dermatitis.

References

    1. Mandlik DS, Mandlik SK. Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharmacol Immunotoxicol. 2021;43(2):105–125. - PubMed
    1. Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on Atopic Dermatitis. Acta Médica Port. 2019;32(9):606–613. - PubMed
    1. Thomsen SF. Atopic Dermatitis: Natural History, Diagnosis, and Treatment. ISRN Allergy. 2014;2014:1–7. - PMC - PubMed
    1. Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups—Variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340–357. - PubMed
    1. Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab. 2015;66(Suppl. 1):8–16. - PubMed

LinkOut - more resources